|Composition of Product||Cefuroxime 500 mg + Clavulanate 125 mg|
|Storage||store in a cool, dry place and avoid direct sunlight|
Cefuroxime 500mg + Clavulanic acid 125mg Salt Information :
Uses of Cefuroxime 500mg + Clavulanic acid 125mg:
Cefuroxime is a cephalosporin antibiotic. Cefuroxime is used in the treatment of various bacterial infections. Cefuroxime is used in infections of respiratory tract infections like pharyngitis, otitis media, sinusitis, and bronchitis.
Side Effects of Cefuroxime 500mg + Clavulanic acid 125mg:
Large doses can cause cerebral irritation and convulsions; nausea, vomiting, diarrhoea, GI disturbances; erythema multiforme, Stevens-Johnson syndrome, epidermal necrolysis. Potentially Fatal: Anaphylaxis, nephrotoxicity, pseudomembranous colitis.
Drug Interactions of Cefuroxime 500mg + Clavulanic acid 125mg:
Probenecid decreases renal clearance of cefuroxime. Potentially Fatal: Nephrotoxicity with aminoglycosides and furosemide.
Contraindications of Cefuroxime 500mg + Clavulanic acid 125mg:
Hypersensitivity to cephalosporins.
Mechanism of Action of Cefuroxime 500mg + Clavulanic acid 125mg:
Cefuroxime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Absorption: Absorbed from the GI tract with peak plasma concentrations after 2-3 hr (oral); may be enhanced by the presence of food. Distribution: Pleural and synovial fluid, sputum, bone and aqueous fluids; CSF (therapeutic concentrations). Crosses the placenta and enters breast milk. Protein-binding: Up to 50%. Metabolism: Rapidly hydrolysed (intestinal mucosa and blood). Excretion: Via the urine by glomerular filtration and renal tubular secretion (as unchanged); via bile (small amounts); 70 min (elimination half-life); prolonged in neonates and renal impairment.